Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Biol Res Nurs. 2014 Sep 16;17(3):321–329. doi: 10.1177/1099800414543822

Table 2.

Inflammatory Biomarkers in Serum and Tissue.

Inflammatory biomarker Control n = 16
M (SD)
Control + drug n = 16
M (SD)
Tumor n = 16
M (SD)
Tumor + drug n = 16
M (SD)
Test statistic
Cytokines
 Serum (pg/ml)
  IL-6 9.4 (9.4) 7.9 (7.7) 241.1 (162.8) 240.5 (166.2) F(1, 64) = 62.8***,a
  TNFR1 690.3 (251.2) 813.4 (204.2) 1284.1 (595.6) 1341.1 (405.6) F(1, 64) = 33.8***,a
 Heart (ddct)
  IL-6 .95 (.69) .50 (.35) 5.7 (2.9) 7.0 (5.8) F(1, 64) = 43.6***,a
  TNFR1 1.0 (.19) .95 (2.0) 2.2 (.60) 3.4 (2.6) F(1, 64) = 27.1***,a
 Gastrocnemius (ddct)
  IL-6 1.1 (1.0) .51 (.23) 1.3 (1.0) 1.8 (2.3) F(1, 64) = 4.2*,a
  TNFR1 1.1 (.47) .94 (.43) 1.7 (.72) 1.7 (.64) F(1, 64) = 22.4***,a
GSH/GSSG (μM)
 Heart 6.8 (3.5) 5.9 (2.1) 3.2 (.6) 3.3 (.78) F(1, 60) = 34.5***,a
 Gastrocnemius 5.2 (1.2) 4.9 (1.3) 4.1 (1.3) 4.9 (1.3) ns

Note. ddct = relative to expression of GAPDH; GADPH = glyceraldehyde-3-phosphate dehydrogenase; IL = interleukin; GSH/GSSG = ratio of reduced sulfhydryl glutathione to oxidized glutathione; TNFR1 = tumor necrosis factor-α type 1 receptor.

a

Main effect of tumor.

*

p < .05.

**

p < .01.

***

p < .001.